Identification of immune and metabolic predictors of severe hand-foot-mouth disease.
Adolescent
Adult
Alkaline Phosphatase
/ blood
Biomarkers
/ blood
Body Temperature
Case-Control Studies
Child
China
Chlorides
/ blood
Eosinophils
/ metabolism
Female
Globulins
/ analysis
Hand, Foot and Mouth Disease
/ blood
Hospitalization
Humans
Immune System
Immunoglobulin G
/ blood
Inflammation
/ blood
Male
Multivariate Analysis
Regression Analysis
Risk Factors
Rural Population
Sodium
/ blood
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
09
2018
accepted:
02
05
2019
entrez:
24
5
2019
pubmed:
24
5
2019
medline:
6
2
2020
Statut:
epublish
Résumé
Hand, foot and mouth disease (HFMD) is an infectious disease that affects mostly children. The children with HFMD also have other immune and metabolic disorders. However, the association of these disorders with the severity of HFMD has not yet been determined. In this study, we used a case-control study design to examine the correlation of immune and metabolic disorders with HFMD development in children. 406 mild and severe patients were recruited and divided into different subgroups based on the number of days from the initial onset time to hospitalization (1, 2, 3, 4, and ≥5 days). Logistic regression model was used to define the predictors of severe HFMD. We found that the patients from rural area (OR = 1.76, 95% CI [1.19~2.63], P = 0.005) or with body temperature of >39°C (OR = 2.14, 95% CI [1.12~4.12], P = 0.022) exhibited higher risk for severe symptoms. In addition, the risk increased with the rise of body temperature by using a Chis-quare trend test (P = 0.01). We also found that a decreased number of eosinophils was an predictor of severe HFMD at 1, 2, 3,and 4 days post infection (dpi). Decreased levels of Na+, Cl-, and creatine kinase were also predictors at 1 and ≥5 dpi. On the other hand, elevated level of globulin was a predictor for severe HFMD at 4 dpi and ≥5 dpi, and the increased number of neutrophils or increased level of alkaline phosphatase posed risk for severe HFMD at 3 and ≥5 dpi. Our results suggested that rural living, hyperpyrexia, changes in the immune system that include the numbers of eosinophils and neutrophils and the levels of IgG and globulin, and metabolic alterations, such as the levels of alkaline phosphatase, Na+, Cl-, and creatine kinase in peripheral blood are predictors of severe HFMD.
Identifiants
pubmed: 31120941
doi: 10.1371/journal.pone.0216993
pii: PONE-D-18-24479
pmc: PMC6532886
doi:
Substances chimiques
Biomarkers
0
Chlorides
0
Globulins
0
Immunoglobulin G
0
Sodium
9NEZ333N27
Alkaline Phosphatase
EC 3.1.3.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216993Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cell. 2009 Jul 10;138(1):30-50
pubmed: 19596234
Ric Clin Lab. 1980 Jul-Sep;10(3):463-79
pubmed: 6775363
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
N Engl J Med. 1999 Sep 23;341(13):929-35
pubmed: 10498487
Comp Med. 2009 Dec;59(6):517-26
pubmed: 20034426
Lancet Neurol. 2010 Nov;9(11):1097-105
pubmed: 20965438
Med Health R I. 2005 Nov;88(11):398, 400-4
pubmed: 16363394
Sci Rep. 2017 Jan 13;7:40282
pubmed: 28084311
PLoS One. 2014 Jan 29;9(1):e87603
pubmed: 24489943
J Virol. 2014 Nov;88(21):12485-99
pubmed: 25142603
Clin Biochem. 1990 Apr;23(2):99-104
pubmed: 2197029
J Virol. 2014 Oct;88(20):11658-70
pubmed: 25078697
N Engl J Med. 1999 Sep 23;341(13):984-5
pubmed: 10498495
Blood. 2014 Jan 30;123(5):743-52
pubmed: 24297871
Lancet Infect Dis. 2010 Nov;10(11):778-90
pubmed: 20961813
J Am Coll Cardiol. 1987 Oct;10(4):837-44
pubmed: 2821091
BMJ. 2001 Jun 16;322(7300):1479-80
pubmed: 11408310
Arch Virol. 2015 Jan;160(1):81-90
pubmed: 25408373
Lancet Infect Dis. 2014 Apr;14(4):308-318
pubmed: 24485991
Evid Based Complement Alternat Med. 2013;2013:647452
pubmed: 23533509
Virusdisease. 2017 Dec;28(4):430-433
pubmed: 29291236
Indian J Pediatr. 2015 Jan;82(1):13-8
pubmed: 24830423
Genet Mol Res. 2016 Sep 23;15(3):
pubmed: 27706779
Curr Opin Virol. 2014 Apr;5:98-104
pubmed: 24727707
Emerg Microbes Infect. 2018 Jan 24;7(1):8
pubmed: 29362406
N Engl J Med. 2014 Feb 27;370(9):829-37
pubmed: 24571755
PLoS One. 2014 Nov 12;9(11):e112676
pubmed: 25391156